CCAIM
Novel AI to transform healthcare
Five members of the Centre’s faculty will publish eighteen papers and three workshops at this year’s conference on Neural Information Processing Systems (NeurIPS 2021), one of the most prestigious international academic conferences …
An extensive new study published in Nature Machine Intelligence shows that a prognostic tool developed by the van der Schaar Lab can recommend therapies for breast cancer patients more reliably than methods …
Using AI with home monitoring to predict sudden dips in the health of adults with cystic fibrosis has been awarded ‘Phase 2’ funding by the government. A pioneering artificial intelligence …
With the help of artificial intelligence, patients should find out whether their rash or a birthmark is dangerous. Experts recognize the advantages of such a tool, but emphasize that it cannot replace a doctor.
The Cambridge Centre for AI in Medicine develops pioneering AI and machine learning technologies with the goal of transforming biomedical science, medicine and healthcare. Another of our goals is to …
Today the University of Cambridge announces a five-year agreement with AstraZeneca and GSK to fund the Cambridge Centre for AI in Medicine (CCAIM). For the 5-year duration, AstraZeneca and GSK …
The question of which patient should receive a life-saving donor organ is one of the thorniest in medicine. Donor organs are a scarce resource, each one as unique as the …
World-leading AI technology developed at the University of Cambridge by the directors of the Cambridge Centre for AI in Medicine and their colleagues offers a glimpse of the future of …
World-leading expertise in healthcare-focused machine learning combined with the world’s largest, high-quality cancer data collection service could lead to a quantum leap in personalised medicine. (This article, featuring the work …
